ArticleStem cell research & therapy2026
Nanofiber-reinforced ECM-based bioink for hybrid biofabrication of adventitia-mimetic anisotropic vascular constructs.
Article in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTissue-engineered blood vessels are essential for vascular grafting. Despite significant progress, current research predominantly focuses on the macroscopic scale of vascular grafts, neglecting the anisotropic microstructure of the vascular wall, particularly the adventitia, which plays a key role in the mechanical stability and functional performance of native vessels. Consequently, this aspect remains underexplored in current vascular tissue engineering strategies, limiting the full potential of vascular graft development.
methodsIn this study, we developed a novel hybrid biofabrication strategy combining electrospinning and coaxial extrusion printing with nanofiber-reinforced bioinks to fabricate vascular constructs that mimic the anisotropic structure of the vessel wall. The bioink, composed of a gelatin methacryloyl hydrogel matrix, contains short electrospun polycaprolactone fibers and vascular-derived extracellular matrix, which improve the mechanical stability, printability, and biocompatibility of the bioink while also providing micro/nano-scale structure.
resultsUsing coaxial extrusion printing, we successfully fabricated vascular constructs with well-aligned fibers and cells oriented along the long axis of the artificial vessel, mimicking the micro-/nano-architecture of the adventitia. Finite element analysis revealed that shear stress during extrusion induced fiber and cell alignment, creating anisotropic structures that enhance the potential for vascular tissue engineering applications. In vivo studies demonstrated that these constructs promote host integration and vascular ingrowth without causing excessive inflammation.
conclusionsA promising strategy for fabricating vascular grafts with biomimetic adventitia-like structures is presented in this study, thereby providing a versatile platform for engineering vascular and other anisotropic tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.